138 related articles for article (PubMed ID: 37804888)
1. Secondary structure and toxicity of transthyretin fibrils can be altered by unsaturated fatty acids.
Ali A; Zhaliazka K; Dou T; Holman AP; Kumar R; Kurouski D
Int J Biol Macromol; 2023 Dec; 253(Pt 7):127241. PubMed ID: 37804888
[TBL] [Abstract][Full Text] [Related]
2. Role of Saturation and Length of Fatty Acids of Phosphatidylserine in the Aggregation of Transthyretin.
Ali A; Zhaliazka K; Dou T; Holman AP; Kurouski D
ACS Chem Neurosci; 2023 Sep; 14(18):3499-3506. PubMed ID: 37676231
[TBL] [Abstract][Full Text] [Related]
3. Saturation of fatty acids in phosphatidic acid uniquely alters transthyretin stability changing morphology and toxicity of amyloid fibrils.
Ali A; Zhaliazka K; Dou T; Holman AP; Kurouski D
Chem Phys Lipids; 2023 Nov; 257():105350. PubMed ID: 37858615
[TBL] [Abstract][Full Text] [Related]
4. Plasmalogens Alter the Aggregation Rate of Transthyretin and Lower Toxicity of Transthyretin Fibrils.
Sitton J; Ali A; Osborne L; Holman AP; Rodriguez A; Kurouski D
J Phys Chem Lett; 2024 May; 15(17):4761-4766. PubMed ID: 38661515
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol and Sphingomyelin Uniquely Alter the Rate of Transthyretin Aggregation and Decrease the Toxicity of Amyloid Fibrils.
Ali A; Zhaliazka K; Dou T; Holman AP; Kurouski D
J Phys Chem Lett; 2023 Dec; 14(49):10886-10893. PubMed ID: 38033106
[TBL] [Abstract][Full Text] [Related]
6. Uncovering the Mechanism of Aggregation of Human Transthyretin.
Saelices L; Johnson LM; Liang WY; Sawaya MR; Cascio D; Ruchala P; Whitelegge J; Jiang L; Riek R; Eisenberg DS
J Biol Chem; 2015 Nov; 290(48):28932-43. PubMed ID: 26459562
[TBL] [Abstract][Full Text] [Related]
7. The importance of a gatekeeper residue on the aggregation of transthyretin: implications for transthyretin-related amyloidoses.
Sant'Anna R; Braga C; Varejão N; Pimenta KM; Graña-Montes R; Alves A; Cortines J; Cordeiro Y; Ventura S; Foguel D
J Biol Chem; 2014 Oct; 289(41):28324-37. PubMed ID: 25086037
[TBL] [Abstract][Full Text] [Related]
8. Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.
Saelices L; Chung K; Lee JH; Cohn W; Whitelegge JP; Benson MD; Eisenberg DS
Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6741-E6750. PubMed ID: 29954863
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale structural characterization of transthyretin aggregates formed at different time points of protein aggregation using atomic force microscopy-infrared spectroscopy.
Rodriguez A; Ali A; Holman AP; Dou T; Zhaliazka K; Kurouski D
Protein Sci; 2023 Dec; 32(12):e4838. PubMed ID: 37967043
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for transthyretin amyloid formation in vitreous body of the eye.
Iakovleva I; Hall M; Oelker M; Sandblad L; Anan I; Sauer-Eriksson AE
Nat Commun; 2021 Dec; 12(1):7141. PubMed ID: 34880242
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.
Si JB; Kim B; Kim JH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922648
[TBL] [Abstract][Full Text] [Related]
12. Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis.
Pinheiro F; Varejão N; Esperante S; Santos J; Velázquez-Campoy A; Reverter D; Pallarès I; Ventura S
FEBS J; 2021 Jan; 288(1):310-324. PubMed ID: 32324953
[TBL] [Abstract][Full Text] [Related]
13. A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis).
Gonzalez-Duarte A; Ulloa-Aguirre A
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884963
[TBL] [Abstract][Full Text] [Related]
14. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
Liang Y; Ore MO; Morin S; Wilson DJ
Biochemistry; 2012 Apr; 51(16):3523-30. PubMed ID: 22482799
[TBL] [Abstract][Full Text] [Related]
15. Unsaturated fatty acids uniquely alter aggregation rate of α-synuclein and insulin and change the secondary structure and toxicity of amyloid aggregates formed in their presence.
Matveyenka M; Zhaliazka K; Kurouski D
FASEB J; 2023 Jul; 37(7):e22972. PubMed ID: 37302013
[TBL] [Abstract][Full Text] [Related]
16. In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.
Hoepfner J; Kleinsorge M; Papp O; Alfken S; Heiringhoff R; Pich A; Sauer V; Zibert A; Göhring G; Schmidt H; Sgodda M; Cantz T
Biol Chem; 2017 Jul; 398(8):939-954. PubMed ID: 28051995
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of transthyretin aggregation and toxicity.
Gasperini RJ; Klaver DW; Hou X; Aguilar MI; Small DH
Subcell Biochem; 2012; 65():211-24. PubMed ID: 23225005
[TBL] [Abstract][Full Text] [Related]
18. A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.
Ueda M; Okada M; Mizuguchi M; Kluve-Beckerman B; Kanenawa K; Isoguchi A; Misumi Y; Tasaki M; Ueda A; Kanai A; Sasaki R; Masuda T; Inoue Y; Nomura T; Shinriki S; Shuto T; Kai H; Yamashita T; Matsui H; Benson MD; Ando Y
J Biol Chem; 2019 Jul; 294(29):11259-11275. PubMed ID: 31167790
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the stabilities of synthetic
Raimondi S; Mangione PP; Verona G; Canetti D; Nocerino P; Marchese L; Piccarducci R; Mondani V; Faravelli G; Taylor GW; Gillmore JD; Corazza A; Pepys MB; Giorgetti S; Bellotti V
J Biol Chem; 2020 Aug; 295(33):11379-11387. PubMed ID: 32571879
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]